These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 7667509)
1. The functional staging of Duchenne muscular dystrophy using in vivo 31P MR spectroscopy. Ikehira H; Nishikawa S; Matsumura K; Hasegawa T; Arimizu N; Tateno Y Radiat Med; 1995; 13(2):63-5. PubMed ID: 7667509 [TBL] [Abstract][Full Text] [Related]
2. Muscle energy metabolism in Duchenne dystrophy studied by 31P-NMR: controlled trials show no effect of allopurinol or ribose. Griffiths RD; Cady EB; Edwards RH; Wilkie DR Muscle Nerve; 1985; 8(9):760-7. PubMed ID: 3935926 [TBL] [Abstract][Full Text] [Related]
3. Muscle energy metabolism in female DMD/BMD carriers: a 31P-MR spectroscopy study. Barbiroli B; Funicello R; Ferlini A; Montagna P; Zaniol P Muscle Nerve; 1992 Mar; 15(3):344-8. PubMed ID: 1557082 [TBL] [Abstract][Full Text] [Related]
4. [31P NMR spectroscopy of muscular diseases: correlation with MR imaging]. Kaiser WA; Hartl W; Sturm H; Schalke BC; Zeitler E Rofo; 1987 Feb; 146(2):137-44. PubMed ID: 3029825 [TBL] [Abstract][Full Text] [Related]
5. Human leg neuromuscular diseases: P-31 MR spectroscopy. Bárány M; Siegel IM; Venkatasubramanian PN; Mok E; Wilbur AC Radiology; 1989 Aug; 172(2):503-8. PubMed ID: 2748832 [TBL] [Abstract][Full Text] [Related]
6. Nuclear magnetic resonance studies of forearm muscle in Duchenne dystrophy. Newman RJ; Bore PJ; Chan L; Gadian DG; Styles P; Taylor D; Radda GK Br Med J (Clin Res Ed); 1982 Apr; 284(6322):1072-4. PubMed ID: 6802410 [TBL] [Abstract][Full Text] [Related]
7. An in vivo study of muscle phosphate metabolism in Becker's dystrophy by 31P NMR spectroscopy. Newman RJ Metabolism; 1985 Aug; 34(8):737-40. PubMed ID: 4021805 [TBL] [Abstract][Full Text] [Related]
9. Brain abnormalities in Duchenne muscular dystrophy: phosphorus-31 magnetic resonance spectroscopy and neuropsychological study. Tracey I; Scott RB; Thompson CH; Dunn JF; Barnes PR; Styles P; Kemp GJ; Rae CD; Pike M; Radda GK Lancet; 1995 May; 345(8960):1260-4. PubMed ID: 7746055 [TBL] [Abstract][Full Text] [Related]
10. [Ultrasound imaging of muscles in Duchenne muscular dystrophy]. Aizawa H; Kozima S; Takagi A Rinsho Shinkeigaku; 1989 Jan; 29(1):49-53. PubMed ID: 2663295 [TBL] [Abstract][Full Text] [Related]
11. [Intramuscular degeneration process in Duchenne muscular dystrophy--investigation by longitudinal MR imaging of the skeletal muscles]. Hasegawa T; Matsumura K; Hashimoto T; Ikehira H; Fukuda H; Tateno Y Rinsho Shinkeigaku; 1992 Mar; 32(3):333-5. PubMed ID: 1628461 [TBL] [Abstract][Full Text] [Related]
12. Reduced cytosolic acidification during exercise suggests defective glycolytic activity in skeletal muscle of patients with Becker muscular dystrophy. An in vivo 31P magnetic resonance spectroscopy study. Lodi R; Kemp GJ; Muntoni F; Thompson CH; Rae C; Taylor J; Styles P; Taylor DJ Brain; 1999 Jan; 122 ( Pt 1)():121-30. PubMed ID: 10050900 [TBL] [Abstract][Full Text] [Related]
13. Heterogeneous metabolic changes in the calf muscle of the rat during ischaemia-reperfusion: in vivo analysis by 31P nuclear magnetic resonance chemical shift imaging and 1H magnetic resonance imaging. Morikawa S; Inubushi T; Kito K Cardiovasc Surg; 1993 Aug; 1(4):337-42. PubMed ID: 8076056 [TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance spectroscopy of the musculoskeletal system. Burt CT; Koutcher J; Roberts JT; London RE; Chance B Radiol Clin North Am; 1986 Jun; 24(2):321-31. PubMed ID: 3459210 [TBL] [Abstract][Full Text] [Related]
15. [NMR-CT in muscular disorders--muscle T1 values in normal children and Duchenne muscular dystrophy patients]. Matsumura K; Nakano I; Ikehira H; Fukuda N; Tateno Y; Aoki Y; Kawai M Rinsho Shinkeigaku; 1986 Jul; 26(7):733-41. PubMed ID: 3769321 [No Abstract] [Full Text] [Related]
16. Proton spin-lattice relaxation time of Duchenne dystrophy skeletal muscle by magnetic resonance imaging. Matsumura K; Nakano I; Fukuda N; Ikehira H; Tateno Y; Aoki Y Muscle Nerve; 1988 Feb; 11(2):97-102. PubMed ID: 3343998 [TBL] [Abstract][Full Text] [Related]
17. Absolute quantification of phosphorus metabolite concentrations in human muscle in vivo by 31P MRS: a quantitative review. Kemp GJ; Meyerspeer M; Moser E NMR Biomed; 2007 Oct; 20(6):555-65. PubMed ID: 17628042 [TBL] [Abstract][Full Text] [Related]
18. Magnetic resonance spectroscopy of normal and diseased muscles. Chance B; Younkin DP; Kelley R; Bank WJ; Berkowitz HD; Argov Z; Donlon E; Boden B; McCully K; Buist NM Am J Med Genet; 1986 Dec; 25(4):659-79. PubMed ID: 2947466 [TBL] [Abstract][Full Text] [Related]
19. [Initial clinical experience with the use of 31P MR spectroscopy in the examination of children with neuromuscular diseases]. Hájek M; Grosmanová A; Horská A; Urban P; Suchánek M; Jirásek A Cesk Neurol Neurochir; 1991 Jul; 54(3):149-56. PubMed ID: 1751972 [TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor and its receptors are related to the progression of human muscular dystrophy: an immunohistochemical study. Zhao Y; Haginoya K; Sun G; Dai H; Onuma A; Iinuma K J Pathol; 2003 Sep; 201(1):149-59. PubMed ID: 12950028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]